Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Kelley, Robin Kate Ueno, Makoto Yoo, Changhoon Finn, Richard S Furuse, Junji Ren, Zhenggang Yau, Thomas Klümpen, Heinz-Josef Chan, Stephen L Ozaka, Masato Verslype, Chris Bouattour, Mohamed Park, Joon Oh Barajas, Olga Pelzer, Uwe Valle, Juan W Yu, Li Malhotra, Usha Siegel, Abby B Edeline, Julien Vogel, Arndt